Qlife Holding AB
Research Qlife Holding AB (QLIFE) on Bullrun: market cap SEK 46.95M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQLIFE
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 46.95M
- Financial periodQ1 2026
- RevenueSEK 21.00K
- Net income-SEK 6.23M
- Free cash flow-SEK 4.20M
- Gross margin-204.8%
Valuation Snapshot
latest market cap is SEK 46.95M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 328.00K | -SEK 20.60M | -SEK 15.82M | -206.4% | -2.23 | SEK 1.42M | SEK 8.55M | -SEK 7.51M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-27 | SEK 46.95M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Qlife Holding AB
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Qlife Holding AB's market cap?
Qlife Holding AB's market capitalization is SEK 46.95M.
What does Qlife Holding AB do?
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.